Business Context and Reporting Period
Company: Utah Medical Products, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 24, 2025
Reporting Period: The filing references financial information for the three and six months ended June 30, 2025, and includes forward-looking statements for 2025 and beyond.
Key Financial Metrics
The provided text serves as a cover sheet for the filing and does not contain specific numerical data. It states that financial information regarding revenue, profit, cash flow, margins, debt, and liquidity is attached as Exhibit 99.1 (a press release dated July 24, 2025). Consequently, the filing text does not provide clear values for these metrics.
Material Changes
The filing text does not detail specific material changes versus prior periods. It indicates that such information is contained within the attached press release (Exhibit 99.1).
Guidance, Outlook, and Risks
- Outlook: The filing incorporates forward-looking statements relating to 2025 and beyond, which are detailed in the attached press release.
- Legal Status: The information furnished under Item 2.02 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section.
- Emerging Growth Company: The registrant has not indicated it is an emerging growth company.
Investor Verification Checklist
- Review Exhibit 99.1 (the press release dated July 24, 2025) for actual revenue, profit, and cash flow figures for the three and six months ended June 30, 2025.
- Verify the specific forward-looking statements and guidance for 2025 contained in the attached exhibit.
- Confirm the company's current liquidity position and debt levels, as these are not listed in the cover text.